Tyler Dylan-Hyde
General Counsel, CRISPR Therapeutics.
Companies
- CRISPR TherapeuticsGeneral counsel Oct 18, 2016 to Jan 18, 20181
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCRISPR Therapeutics, General counsel